|
ANKRD36 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.98690019571313E-10 |
| Normal-vs-Stage3 |
3.31840110945336E-11 |
| Normal-vs-Stage4 |
1.59300350688341E-11 |
| Stage1-vs-Stage2 |
3.464800E-01 |
| Stage1-vs-Stage3 |
1.321200E-01 |
| Stage1-vs-Stage4 |
6.772800E-01 |
| Stage2-vs-Stage3 |
5.884800E-01 |
| Stage2-vs-Stage4 |
6.452200E-01 |
| Stage3-vs-Stage4 |
3.103000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.54176712799881E-12 |
| Normal-vs-Asian |
9.836600E-03 |
| Caucasian-vs-AfricanAmerican |
1.521750E-01 |
| Caucasian-vs-Asian |
2.127200E-01 |
| AfricanAmerican-vs-Asian |
3.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.228250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.013160E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.243720E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.831600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.570200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.707800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.608600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.042800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.620200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.794800E-04 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.41169964607002E-10 |
| Grade 1-vs-Grade 2 |
2.595600E-01 |
| Grade 1-vs-Grade 3 |
4.052200E-01 |
| Grade 1-vs-Grade 4 |
1.260560E-01 |
| Grade 2-vs-Grade 3 |
8.693400E-01 |
| Grade 2-vs-Grade 4 |
4.363400E-01 |
| Grade 3-vs-Grade 4 |
3.866800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.03173025678416E-12 |
| ccA subtype-vs-ccB subtype |
2.694400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62436730732907E-12 |
| Normal-vs-N1 |
5.663800E-03 |
| N0-vs-N1 |
2.474000E-01 |
|
|
